AUSTIN (KXAN) – An infusion center to treat COVID-19 patients is due to open in Austin on Wednesday, thanks to the Texas Department of Emergency Management.
A discharge from Governor Greg Abbott’s office stated that the therapeutic infusion center will treat outpatient cases that meet certain criteria and receive a referral from a hospital or doctor with Regeneron.
Regeneron Pharmaceuticals created a cocktail of two monoclonal antibodies – casirivimab and imdevimab – to help relieve symptoms of the coronavirus. The treatment was approved for emergency by the U.S. Food and Drug Administration in November 2020.
The center was made possible through a partnership between TDEM, Travis County, the City of Austin, and the Regional Advisory Board on Trauma in the Capital Area.
“This infusion center will help us expand access to therapeutic treatments for COVID-19 in the Austin community,” Abbott said in a press release. “Reducing hospital stays is a critical part of our response to COVID-19. We will continue to work with our local partners to ensure they have the resources they need to protect their communities.”
FULL COVERAGE: The latest coronavirus news in Austin, Texas, the US and the world
Right now, health officials in the Austin and Travis Counties are concerned as the number of hospitalizations related to the virus increases.
MORE: Austin is working with the state to advance more COVID-19 antibody therapy
Other forms of monoclonal antibody therapy have been used in the Austin area, including bamlanivimab, developed by Eli Lilly and Company. This treatment was also approved by the FDA for emergency use in November 2020.